Nasopharyngeal Cancer

Nasopharyngeal cancer is a malignant tumor arising from the epithelial lining of the nasopharynx, the upper part of the pharynx located behind the nasal cavity. Nasopharyngeal carcinoma is the predominant histological tumor type affecting this region.

Due to the deep anatomical location of the nasopharynx and its close relationship with critical structures such as the skull base and cranial nerves, diagnosis is often delayed and radical surgical treatment is usually not feasible. Management relies mainly on radiotherapy, with chemotherapy added according to disease stage.

Epidemiology

Nasopharyngeal carcinoma has a distinct geographic distribution and is more common in certain populations and regions. It differs from many other head and neck cancers due to its strong association with viral, genetic, and environmental factors.

Patients commonly present with locally advanced disease because early symptoms are often nonspecific.

Risk factors

Risk factors associated with nasopharyngeal carcinoma include:

• Epstein–Barr virus (EBV) infection.

• Family history of nasopharyngeal cancer.

• Genetic susceptibility.

• Consumption of preserved foods containing nitrosamines.

• Tobacco exposure.

• Alcohol consumption.

• Environmental exposures.

Pathophysiology

Nasopharyngeal carcinoma develops from malignant transformation of epithelial cells within the nasopharyngeal mucosa.

The tumor may spread through:

• Local invasion into surrounding structures.

• Extension to the skull base.

• Cranial nerve involvement.

• Regional lymphatic spread to cervical lymph nodes.

• Distant metastasis through hematogenous dissemination.

Common metastatic sites include:

• Bone.

• Lung.

• Liver.

Clinical presentation

Nasopharyngeal cancer may present with symptoms related to:

• Nasopharyngeal obstruction.

• Middle ear dysfunction.

• Cervical lymph node involvement.

• Cranial nerve compression.

Because the nasopharynx is located deep within the head and neck, visible primary lesions are uncommon without specialized examination.

Symptoms

Common symptoms include:

• Neck mass.

• Unilateral hearing loss.

• Tinnitus.

• Nasal obstruction.

• Epistaxis.

• Facial symptoms.

• Headache.

• Cranial nerve-related symptoms.

Advanced disease may present with:

• Neurological symptoms due to skull base invasion.

• Symptoms related to distant metastasis.

Clinical signs

Clinical findings may include:

• Cervical lymphadenopathy.

• Nasal obstruction.

• Evidence of nasopharyngeal mass.

• Cranial nerve palsies.

• Middle ear effusion or hearing abnormalities.

• Signs of metastatic disease in advanced cases.

Differential diagnosis

Conditions that may mimic nasopharyngeal carcinoma include:

• Nasopharyngeal polyps.

• Chronic sinusitis.

• Benign nasopharyngeal tumors.

• Lymphoma.

• Adenoid hypertrophy.

• Tuberculosis involving cervical lymph nodes.

• Other head and neck malignancies.

Diagnostic criteria

Nasopharyngeal carcinoma should be suspected in patients presenting with:

• Persistent neck mass.

• Unilateral hearing loss.

• Persistent tinnitus.

• Nasal obstruction.

• Recurrent epistaxis.

• Cranial nerve palsies.

Definitive diagnosis requires histological confirmation from biopsy of the primary tumor.

Investigations

Laboratory investigations

• Full blood count (FBC).

• Renal function tests (RFT).

• Liver function tests (LFT).

• HIV test.

Imaging investigations

• Chest X-ray (CXR).

• Abdominal ultrasound.

• Computed tomography (CT) scan of:

  • Nasopharynx.

  • Skull base.

  • Neck.

• Magnetic resonance imaging (MRI) of:

  • Nasopharynx.

  • Skull base.

  • Neck.

• Positron emission tomography-computed tomography (PET/CT).

Endoscopic evaluation

• Nasopharyngoscopy.

Histopathological investigations

• Endoscopic-guided biopsy of the primary tumor.

Immunohistochemistry

• Immunohistochemistry may be performed to further confirm diagnosis and characterize the tumor.

Diagnostic staging

Nasopharyngeal carcinoma is staged using:

• TNM staging system.

Management

Management depends on:

• Disease stage.

• Tumor extent.

• Presence of lymph node involvement.

• Presence of distant metastasis.

• Patient general condition.

Due to the deep location of the nasopharynx and proximity to vital structures, radical surgery is generally not used as the primary treatment.

The main treatment modalities are:

• Radiotherapy.

• Chemotherapy.

• Supportive and palliative care.

Non-pharmacological treatment

Surgery

Surgery has a limited role in nasopharyngeal carcinoma.

Diagnostic role

The main surgical role is:

• Obtaining biopsy specimens for histological confirmation.

Neck management

Surgery may be considered for:

• Persistent enlarged cervical lymph nodes after primary treatment.

Radiotherapy

Radiotherapy is the main treatment modality because nasopharyngeal carcinoma is highly radiosensitive.

Management according to disease stage

Induction chemotherapy

Induction chemotherapy may be considered for:

• Stage III–IVB disease.

• Situations where delays are anticipated before initiation of concurrent chemotherapy and radiotherapy.

Local recurrence

Management options include:

• Chemotherapy.

• Surgery.

• Re-irradiation.

Pharmacological treatment

(No specific chemotherapy regimen was provided in the source information; therefore, no drug doses or schedules are added.)

Chemotherapy is used:

• Concurrently with radiotherapy for locally advanced disease.

• As induction therapy in selected stage III–IVB disease.

• For recurrent or metastatic disease as palliative treatment.

Management according to disease stage

Stage I disease

• Definitive radiotherapy to the primary tumor and neck.

Stage II–IVB disease

• Concurrent chemotherapy and radiotherapy.

• Consider induction chemotherapy when treatment delays are expected.

Stage IVC disease

• Palliative treatment.

• Symptom control.

• Chemotherapy and/or radiotherapy depending on clinical condition.

Local recurrence

Treatment options include:

• Chemotherapy.

• Surgical management in selected cases.

• Re-irradiation.

Referral

All patients with suspected or confirmed nasopharyngeal carcinoma should be referred to a specialized oncology center for:

• Endoscopic evaluation.

• Histological confirmation.

• Staging.

• Definitive treatment planning.

Urgent referral is required for:

• Persistent neck masses.

• Cranial nerve palsies.

• Unexplained unilateral hearing loss.

• Persistent epistaxis.

Complications

Complications may result from disease progression or treatment and include:

• Cervical lymph node metastasis.

• Cranial nerve palsies.

• Skull base invasion.

• Hearing impairment.

• Airway obstruction.

• Distant metastases.

• Treatment-related complications.

• Local recurrence.

Prognosis

Prognosis depends on:

• Disease stage at diagnosis.

• Tumor extension.

• Lymph node involvement.

• Presence of distant metastases.

• Response to radiotherapy and chemotherapy.

Early-stage disease has better outcomes, while metastatic disease carries a poorer prognosis.

Prevention

Preventive strategies include:

• Early evaluation of persistent ENT symptoms.

• Avoidance of tobacco exposure.

• Reduction of alcohol consumption.

• Awareness among high-risk populations.

• Prompt investigation of persistent neck swelling or unilateral hearing symptoms.

Follow-up

Patients require regular follow-up after treatment to assess:

• Treatment response.

• Local recurrence.

• Regional lymph node recurrence.

• Distant metastasis.

• Treatment complications.

Follow-up may include:

• Clinical examination.

• Nasopharyngoscopy when indicated.

• Imaging studies when clinically required.